UMIN ID: UMIN000000817
Registered date:05/09/2007
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Non-small cell lung cancer |
| Date of first enrollment | 2007/06/01 |
| Target sample size | 32 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | June, 2007-December, 2008 Regimen: TS-1 |
Outcome(s)
| Primary Outcome | Response rate, time to progression, toxicity |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Massive pleural effusion 2) Massivepericardial effusion 3) Interstitial pneumonitis 4) Uncontrolled brain metastasis 5) Active infection |
Related Information
| Primary Sponsor | Nagasaki Thoracic Oncology Group |
|---|---|
| Secondary Sponsor | None |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Takashi Kasai |
| Address | 3-15 Mori-machi, Nagasaki, Japan Japan |
| Telephone | 095-847-1511 |
| takasai@tochigi-cc.jp | |
| Affiliation | Japanese Red Cross Nagasaki Atomic Bomb Hospital Internal Medicine |
| scientific contact | |
| Name | Shigeru Kohno |
| Address | 1-7-1, Sakamoto, Nagasaki, Japan Japan |
| Telephone | 095-849-7273 |
| naho-k@mue.biglobe.ne.jp | |
| Affiliation | Nagasaki University School of Medicine Second Department of Internal Medicine |